Colossal Biosciences, a company known for its de-extinction projects, is collaborating with the U.S. Fish and Wildlife Service to establish a comprehensive biobank dedicated to preserving the DNA of every species currently listed as endangered. This ambitious project seeks to safeguard the genetic diversity of vulnerable wildlife.
The initiative involves collecting biological samples from endangered animals in a minimally invasive manner. While blood draws and skin biopsies are currently the primary methods used in the field, the company is also exploring opportunities to collect organ cells and gametes, such as eggs and sperm. Colossal Biosciences actively seeks out the remains of endangered species found in the wild and collaborates with zoos that are willing to partner following an animal's death to obtain these valuable genetic resources.
Initial discussions with government officials, such as U.S. Fish and Wildlife Service Director Nesvik, focused on a more limited scope, perhaps a hundred species. However, Colossal Biosciences proposed a broader aspiration: to collect samples from every species on the endangered list. The challenge lies not only in identifying and accessing these animals, which are often rare and difficult to locate, but also in ensuring the collection process itself does not further endanger them. The biobank is intended to serve as a crucial resource for future conservation and potential de-extinction efforts.